Resultado da Busca
The mission of IRIS is to help veterinary practitioners better diagnose, understand and treat kidney disease in cats and dogs. We hope you find this site useful and informative. IRIS Staging of Chronic Kidney Disease (CKD) - including algorithms. IRIS Treatment Recommendations for CKD.
- Guidelines
One of the organization's primary objectives is to establish...
- Education
Welcome to the website of the International Renal Interest...
- Emerging Themes
IRIS Emerging Themes To complement the Education Topics...
- About
What Is IRIS? IRIS is the International Renal Interest...
- Hemodialysis Academy
IRIS is pleased to announce its sponsorship of the 4th...
- IRIS Staging of CKD
Staging of chronic kidney disease (CKD) is undertaken...
- Iris Projects
Further details on this project are available in the IRIS...
- Newsletters
A persistent increase in SDMA above 14 µg/dl suggests...
- Guidelines
One of the organization's primary objectives is to establish an internationally recognized set of guidelines on the diagnosis and assessment of renal disease in small animals (IRIS Staging of Chronic Kidney Disease, CKD).
Staging of chronic kidney disease (CKD) is undertaken following the diagnosis of CKD in order to facilitate appropriate treatment and monitoring of the patient. Staging is based initially on fasting blood creatinine, assessed on at least two occasions in the stable patient.
IRIS Treatment Recommendations for CKD. All treatments for chronic kidney disease (CKD) need to be tailored to the individual patient. The following recommendations are useful starting points for the majority of animals at each stage.
What Is IRIS? IRIS is the International Renal Interest Society. IRIS was created to advance the scientific understanding of kidney disease in small animals.
Veja iris-kidney.com para o estadiamento mais detalhado e orientações sobre manejo. A doença renal crônica (DRC) é diagnosticada com base na avaliação de toda informação clínica e diagnóstica em um paciente estável. O Conselho IRIS continua recomendando a utilização da creatinina para o diagnóstico e estadiamento da DRC por ser um
Angiotensin receptor blockers should be the first line treatment rather than ACE inhibitors together with a clinical renal diet. This change is based on recent published evidence of randomised controlled clinical trials.
